Prominent GI Oncologist Dr. Rachna Shroff Passes Away at 47

Rachna Shroff, a prominent physician-scientist and expert in gastrointestinal cancers, passed away on October 11, 2026, after a battle with terminal gastric adenocarcinoma at the age of 47.

Shroff was the associate director of clinical investigations at the University of Arizona Cancer Center, chief of the Division of Hematology/Oncology, and served as associate dean for clinical and translational research at the College of Medicine — Tucson. She was a prominent figure within the field of oncology research, during which she authored more than 80 publications and also headed breakthrough clinical trials which largely expanded treatment options for complex pancreatic and biliary tract cancers.

In May 2026, Shroff noticed a swollen lymph node and initially suspected a lymphoma diagnosis. However, after further testing, it was then confirmed to be aggressive terminal gastric adenocarcinoma — the very disease she had spent her life trying to eradicate.

Despite her terminal diagnosis, Shroff used her final months to inspire colleagues and continue pushing for progress in cancer research. She publicly shared her journey to highlight the importance of trial funding and mentorship for young researchers, living by her personal motto: "If you can’t find the sunshine, be the sunshine."

In the months following her diagnosis, Shroff channeled her energy into the creation of the Conquer Cancer – Rachna Shroff, MD, MS, FASCO Endowed Young Investigator Award in Biliary Cancers. Within weeks, with the help of friends, family, and colleagues, she raised over $1.35 million to permanently endow the award.

Reflecting on the campaign shortly before her death, Shroff wrote: "My absolute greatest passion has been advancing cancer research—particularly in biliary tract cancers—and supporting the brilliant young minds dedicated to finding cures."

In her final weeks, Shroff also worked closely with organizations like the American Society of Clinical Oncology (ASCO), the SWOG Cancer Research Network, and the Cholangiocarcinoma Foundation to advocate for increased research funding. Her work and leadership have brought much-needed attention to areas of gastrointestinal oncology that are underfunded, which will leave a lasting impact on both patients and the scientific community.